文献速递细菌感染、耐药与抗菌药物

治疗药物监测对青霉素治疗患者健康结局影响的系统评价

A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该系统评价纳入3项随机对照试验、16项队列研究和9项病例研究,评估青霉素治疗药物监测(TDM)对健康结局及抗菌药物耐药(AMR)的影响。无随机对照试验显示健康结局有统计学显著改善,5项队列研究显示至少一项健康结局与达标情况改善相关,但所有研究健康结局均存在高偏倚风险。仅1项研究评估TDM对AMR的影响,发现达标改善与耐药抑制相关。结论认为TDM改善健康结局的证据很少,健康结局和AMR影响均未被充分探讨,TDM实施差异大不适合Meta分析,需要标准化方案和浓度目标。

要点

  • 无随机对照试验显示青霉素TDM使健康结局有统计学显著改善。
  • 5项队列研究显示至少一项健康结局与目标 attainment 改善相关,但所有研究健康结局偏倚风险高。
  • 仅1项研究评估TDM对AMR影响,发现达标改善与耐药抑制相关,无研究发现TDM有害。

核心结论

  • TDM改善健康结局的证据很少,但健康结局和AMR影响均未被充分探讨。
  • TDM实施差异大导致不适合Meta分析,TDM需要标准化但目前无明确最佳条件证据。
  • 需要足够把握度的研究来解决TDM对临床结局(包括AMR)影响的不确定性。
  • 需要确定标准化方案和浓度目标才能成功实施TDM。

研究设计与样本

  • 系统评价,纳入测量患者样本中青霉素浓度并根据结果调整方案且报告健康结局的研究。
  • 共纳入3项随机对照试验、16项队列研究和9项病例研究。
  • 根据研究类型评估研究偏倚,纳入研究特征列表并进行叙述性综合。

主要发现

  • 无随机对照试验显示健康结局有统计学显著改善。
  • 5项队列研究显示至少一项健康结局与目标 attainment 改善相关。
  • 所有研究健康结局均存在高偏倚风险。
  • 1项研究评估青霉素TDM对AMR的影响,发现达标改善与耐药抑制相关。
  • 无研究发现青霉素TDM有不利影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有研究健康结局均存在高偏倚风险。
  • 健康结局和AMR影响均未被充分探讨。
  • TDM实施差异大导致不适合Meta分析。
  • 目前无明确最佳条件证据。
  • 需要足够把握度的研究来解决TDM对临床结局(包括AMR)影响的不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dosing regimens guided by therapeutic drug monitoring (TDM) may be able to improve penicillin exposure in patients, which could result in improved patient health outcomes. OBJECTIVES: This systematic review aims to describe the impact penicillin TDM has on health outcomes, including antimicrobial resistance (AMR). METHODS: Studies measuring penicillins in patient samples that adjusted regimens according to the result, and reported health outcomes were selected. Study bias was assessed according to study type. Included study characteristics were tabulated and described by narrative synthesis. RESULTS: Three randomized controlled trials (RCTs), 16 cohort studies, and 9 case studies were included. No RCTs showed statistically significant improvements in health outcomes. Five cohort studies showed improvement in at least one health outcome associated with target attainment. However, there was a high risk of bias in all studies for health outcomes. One study assessed the impact of penicillin TDM on AMR and found that improved target attainment was associated with suppression of resistance. No studies found a detrimental effect of penicillin TDM. CONCLUSIONS: There is little evidence to suggest that TDM improves health outcomes, however neither health outcomes nor impact on AMR were adequately addressed. Variations in TDM implementation meant that a meta-analysis was not suitable. Penicillin TDM needs standardization, however there is currently no clear evidence of optimal conditions. Suitably powered studies are required to resolve the ambiguity surrounding the impact of TDM on clinical outcomes, including AMR. Further, standardized protocols and concentration targets need to be identified for TDM to be implemented successfully.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Luxton T, King N, Wälti C, et al. A systematic review of the effect of therapeutic drug monitoring on patient health outcomes during treatment with penicillins. J Antimicrob Chemother. 2022. PMID: 35355067. doi:10.1093/jac/dkac101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。